nodes	percent_of_prediction	percent_of_DWPC	metapath
Clomipramine—Hepatitis acute—Octreotide—thymus cancer	0.0467	0.0591	CcSEcCtD
Clomipramine—HTR2A—phrenic nerve—thymus cancer	0.0449	0.213	CbGeAlD
Clomipramine—Faeces discoloured—Octreotide—thymus cancer	0.039	0.0495	CcSEcCtD
Clomipramine—Goitre—Octreotide—thymus cancer	0.019	0.024	CcSEcCtD
Clomipramine—HTR2A—pulmonary artery—thymus cancer	0.0163	0.0772	CbGeAlD
Clomipramine—Prostatic disorder—Octreotide—thymus cancer	0.0159	0.0202	CcSEcCtD
Clomipramine—HTR2A—vein—thymus cancer	0.0148	0.0702	CbGeAlD
Clomipramine—Ulcerative stomatitis—Octreotide—thymus cancer	0.0147	0.0186	CcSEcCtD
Clomipramine—Renal pain—Octreotide—thymus cancer	0.0129	0.0163	CcSEcCtD
Clomipramine—Multiple fractures—Octreotide—thymus cancer	0.0116	0.0148	CcSEcCtD
Clomipramine—Fracture—Octreotide—thymus cancer	0.0116	0.0148	CcSEcCtD
Clomipramine—Haemorrhoids—Octreotide—thymus cancer	0.0115	0.0146	CcSEcCtD
Clomipramine—Transaminases increased—Octreotide—thymus cancer	0.0111	0.0141	CcSEcCtD
Clomipramine—Hypothyroidism—Octreotide—thymus cancer	0.0105	0.0134	CcSEcCtD
Clomipramine—Galactorrhoea—Octreotide—thymus cancer	0.0104	0.0132	CcSEcCtD
Clomipramine—Peptic ulcer—Octreotide—thymus cancer	0.0101	0.0128	CcSEcCtD
Clomipramine—Paranoia—Octreotide—thymus cancer	0.00993	0.0126	CcSEcCtD
Clomipramine—Seborrhoeic dermatitis—Octreotide—thymus cancer	0.00993	0.0126	CcSEcCtD
Clomipramine—Intestinal obstruction—Octreotide—thymus cancer	0.00993	0.0126	CcSEcCtD
Clomipramine—Menstrual disorder—Octreotide—thymus cancer	0.00993	0.0126	CcSEcCtD
Clomipramine—Neuralgia—Octreotide—thymus cancer	0.00975	0.0124	CcSEcCtD
Clomipramine—Otitis media—Octreotide—thymus cancer	0.0087	0.011	CcSEcCtD
Clomipramine—Nephrolithiasis—Octreotide—thymus cancer	0.00842	0.0107	CcSEcCtD
Clomipramine—Endocrine disorder—Octreotide—thymus cancer	0.00817	0.0104	CcSEcCtD
Clomipramine—Acne—Octreotide—thymus cancer	0.00805	0.0102	CcSEcCtD
Clomipramine—HRH2—hematopoietic system—thymus cancer	0.0079	0.0374	CbGeAlD
Clomipramine—Contusion—Octreotide—thymus cancer	0.00776	0.00983	CcSEcCtD
Clomipramine—Breast pain—Octreotide—thymus cancer	0.00776	0.00983	CcSEcCtD
Clomipramine—Amenorrhoea—Octreotide—thymus cancer	0.00771	0.00977	CcSEcCtD
Clomipramine—GSTP1—neck—thymus cancer	0.00764	0.0362	CbGeAlD
Clomipramine—Rectal haemorrhage—Octreotide—thymus cancer	0.0075	0.0095	CcSEcCtD
Clomipramine—Cellulitis—Octreotide—thymus cancer	0.00745	0.00944	CcSEcCtD
Clomipramine—Arthropathy—Octreotide—thymus cancer	0.00745	0.00944	CcSEcCtD
Clomipramine—Muscle twitching—Octreotide—thymus cancer	0.00689	0.00874	CcSEcCtD
Clomipramine—Vaginal inflammation—Octreotide—thymus cancer	0.00677	0.00858	CcSEcCtD
Clomipramine—Phosphatase alkaline increased—Octreotide—thymus cancer	0.00677	0.00858	CcSEcCtD
Clomipramine—Eructation—Octreotide—thymus cancer	0.00665	0.00843	CcSEcCtD
Clomipramine—Cystitis noninfective—Octreotide—thymus cancer	0.00661	0.00838	CcSEcCtD
Clomipramine—Cystitis—Octreotide—thymus cancer	0.00654	0.00829	CcSEcCtD
Clomipramine—Vaginal infection—Octreotide—thymus cancer	0.00639	0.0081	CcSEcCtD
Clomipramine—Neuropathy—Octreotide—thymus cancer	0.00636	0.00806	CcSEcCtD
Clomipramine—Cramps of lower extremities—Octreotide—thymus cancer	0.00622	0.00788	CcSEcCtD
Clomipramine—Mouth ulceration—Octreotide—thymus cancer	0.00612	0.00776	CcSEcCtD
Clomipramine—Bladder pain—Octreotide—thymus cancer	0.00612	0.00776	CcSEcCtD
Clomipramine—Urine output increased—Octreotide—thymus cancer	0.00612	0.00776	CcSEcCtD
Clomipramine—Gynaecomastia—Octreotide—thymus cancer	0.00606	0.00768	CcSEcCtD
Clomipramine—HRH2—cardiac atrium—thymus cancer	0.006	0.0284	CbGeAlD
Clomipramine—Hyperkinesia—Octreotide—thymus cancer	0.0059	0.00748	CcSEcCtD
Clomipramine—GSTP1—hematopoietic system—thymus cancer	0.00569	0.027	CbGeAlD
Clomipramine—Sleep disorder—Octreotide—thymus cancer	0.00568	0.0072	CcSEcCtD
Clomipramine—Thrombophlebitis—Octreotide—thymus cancer	0.00568	0.0072	CcSEcCtD
Clomipramine—Diabetes mellitus—Octreotide—thymus cancer	0.00565	0.00716	CcSEcCtD
Clomipramine—Blood alkaline phosphatase increased—Octreotide—thymus cancer	0.00565	0.00716	CcSEcCtD
Clomipramine—Polyuria—Octreotide—thymus cancer	0.0056	0.00709	CcSEcCtD
Clomipramine—Deafness—Octreotide—thymus cancer	0.00549	0.00696	CcSEcCtD
Clomipramine—Cardiac failure congestive—Octreotide—thymus cancer	0.00542	0.00687	CcSEcCtD
Clomipramine—Hot flush—Octreotide—thymus cancer	0.00525	0.00666	CcSEcCtD
Clomipramine—Menopausal symptoms—Octreotide—thymus cancer	0.00521	0.0066	CcSEcCtD
Clomipramine—GSTP1—epithelium—thymus cancer	0.0052	0.0246	CbGeAlD
Clomipramine—Anaphylactoid reaction—Octreotide—thymus cancer	0.00508	0.00644	CcSEcCtD
Clomipramine—Gastrointestinal haemorrhage—Octreotide—thymus cancer	0.00491	0.00623	CcSEcCtD
Clomipramine—Osteoarthritis—Octreotide—thymus cancer	0.00491	0.00623	CcSEcCtD
Clomipramine—Psychotic disorder—Octreotide—thymus cancer	0.0048	0.00608	CcSEcCtD
Clomipramine—SLC6A4—hematopoietic system—thymus cancer	0.00473	0.0224	CbGeAlD
Clomipramine—Irritability—Octreotide—thymus cancer	0.00469	0.00595	CcSEcCtD
Clomipramine—HRH2—lung—thymus cancer	0.00459	0.0217	CbGeAlD
Clomipramine—Dehydration—Octreotide—thymus cancer	0.00457	0.00579	CcSEcCtD
Clomipramine—Dry skin—Octreotide—thymus cancer	0.0045	0.00571	CcSEcCtD
Clomipramine—Gastritis—Octreotide—thymus cancer	0.00435	0.00551	CcSEcCtD
Clomipramine—Muscular weakness—Octreotide—thymus cancer	0.00433	0.00549	CcSEcCtD
Clomipramine—GSTP1—cardiac atrium—thymus cancer	0.00432	0.0205	CbGeAlD
Clomipramine—GSTP1—pituitary gland—thymus cancer	0.00422	0.02	CbGeAlD
Clomipramine—Bronchospasm—Octreotide—thymus cancer	0.00418	0.0053	CcSEcCtD
Clomipramine—Sweating increased—Octreotide—thymus cancer	0.00414	0.00524	CcSEcCtD
Clomipramine—Bronchitis—Octreotide—thymus cancer	0.00409	0.00518	CcSEcCtD
Clomipramine—GSTP1—lymphoid tissue—thymus cancer	0.004	0.019	CbGeAlD
Clomipramine—Dysuria—Octreotide—thymus cancer	0.00397	0.00503	CcSEcCtD
Clomipramine—Pollakiuria—Octreotide—thymus cancer	0.00392	0.00497	CcSEcCtD
Clomipramine—CYP2C19—hematopoietic system—thymus cancer	0.00392	0.0186	CbGeAlD
Clomipramine—Weight increased—Octreotide—thymus cancer	0.00387	0.0049	CcSEcCtD
Clomipramine—Weight decreased—Octreotide—thymus cancer	0.00384	0.00487	CcSEcCtD
Clomipramine—Hyperglycaemia—Octreotide—thymus cancer	0.00383	0.00486	CcSEcCtD
Clomipramine—Pneumonia—Octreotide—thymus cancer	0.00381	0.00483	CcSEcCtD
Clomipramine—Drowsiness—Octreotide—thymus cancer	0.00379	0.0048	CcSEcCtD
Clomipramine—Depression—Octreotide—thymus cancer	0.00378	0.00479	CcSEcCtD
Clomipramine—Neuropathy peripheral—Octreotide—thymus cancer	0.00371	0.00471	CcSEcCtD
Clomipramine—Jaundice—Octreotide—thymus cancer	0.00369	0.00468	CcSEcCtD
Clomipramine—Conjunctivitis—Octreotide—thymus cancer	0.00368	0.00467	CcSEcCtD
Clomipramine—Urinary tract infection—Octreotide—thymus cancer	0.00368	0.00467	CcSEcCtD
Clomipramine—GSTP1—bone marrow—thymus cancer	0.00365	0.0173	CbGeAlD
Clomipramine—GSTP1—thyroid gland—thymus cancer	0.00364	0.0172	CbGeAlD
Clomipramine—Haematuria—Octreotide—thymus cancer	0.00361	0.00458	CcSEcCtD
Clomipramine—Hepatobiliary disease—Octreotide—thymus cancer	0.00358	0.00454	CcSEcCtD
Clomipramine—Epistaxis—Octreotide—thymus cancer	0.00357	0.00453	CcSEcCtD
Clomipramine—Sinusitis—Octreotide—thymus cancer	0.00355	0.0045	CcSEcCtD
Clomipramine—Bradycardia—Octreotide—thymus cancer	0.00346	0.00439	CcSEcCtD
Clomipramine—Rhinitis—Octreotide—thymus cancer	0.00341	0.00432	CcSEcCtD
Clomipramine—Hepatitis—Octreotide—thymus cancer	0.0034	0.00431	CcSEcCtD
Clomipramine—Hypoaesthesia—Octreotide—thymus cancer	0.00338	0.00429	CcSEcCtD
Clomipramine—Pharyngitis—Octreotide—thymus cancer	0.00337	0.00428	CcSEcCtD
Clomipramine—HTR2A—neck—thymus cancer	0.00336	0.0159	CbGeAlD
Clomipramine—GSTP1—lung—thymus cancer	0.0033	0.0157	CbGeAlD
Clomipramine—Visual impairment—Octreotide—thymus cancer	0.00328	0.00415	CcSEcCtD
Clomipramine—CYP1A2—hematopoietic system—thymus cancer	0.0032	0.0152	CbGeAlD
Clomipramine—Tinnitus—Octreotide—thymus cancer	0.00317	0.00402	CcSEcCtD
Clomipramine—Cardiac disorder—Octreotide—thymus cancer	0.00316	0.004	CcSEcCtD
Clomipramine—Flushing—Octreotide—thymus cancer	0.00316	0.004	CcSEcCtD
Clomipramine—HRH2—lymph node—thymus cancer	0.00314	0.0149	CbGeAlD
Clomipramine—Immune system disorder—Octreotide—thymus cancer	0.00307	0.00389	CcSEcCtD
Clomipramine—Arrhythmia—Octreotide—thymus cancer	0.00304	0.00385	CcSEcCtD
Clomipramine—Alopecia—Octreotide—thymus cancer	0.003	0.00381	CcSEcCtD
Clomipramine—HTR2B—thyroid gland—thymus cancer	0.003	0.0142	CbGeAlD
Clomipramine—Mental disorder—Octreotide—thymus cancer	0.00298	0.00378	CcSEcCtD
Clomipramine—Malnutrition—Octreotide—thymus cancer	0.00296	0.00375	CcSEcCtD
Clomipramine—ADRA2A—hematopoietic system—thymus cancer	0.00294	0.014	CbGeAlD
Clomipramine—Flatulence—Octreotide—thymus cancer	0.00292	0.0037	CcSEcCtD
Clomipramine—Tension—Octreotide—thymus cancer	0.0029	0.00368	CcSEcCtD
Clomipramine—Nervousness—Octreotide—thymus cancer	0.00287	0.00364	CcSEcCtD
Clomipramine—Back pain—Octreotide—thymus cancer	0.00286	0.00363	CcSEcCtD
Clomipramine—Muscle spasms—Octreotide—thymus cancer	0.00285	0.00361	CcSEcCtD
Clomipramine—Vision blurred—Octreotide—thymus cancer	0.00279	0.00354	CcSEcCtD
Clomipramine—Tremor—Octreotide—thymus cancer	0.00277	0.00351	CcSEcCtD
Clomipramine—SLC6A4—lung—thymus cancer	0.00275	0.013	CbGeAlD
Clomipramine—Ill-defined disorder—Octreotide—thymus cancer	0.00275	0.00348	CcSEcCtD
Clomipramine—Anaemia—Octreotide—thymus cancer	0.00274	0.00347	CcSEcCtD
Clomipramine—HTR2B—lung—thymus cancer	0.00272	0.0129	CbGeAlD
Clomipramine—Agitation—Octreotide—thymus cancer	0.00272	0.00345	CcSEcCtD
Clomipramine—Malaise—Octreotide—thymus cancer	0.00267	0.00338	CcSEcCtD
Clomipramine—Vertigo—Octreotide—thymus cancer	0.00266	0.00337	CcSEcCtD
Clomipramine—Syncope—Octreotide—thymus cancer	0.00265	0.00336	CcSEcCtD
Clomipramine—Palpitations—Octreotide—thymus cancer	0.00262	0.00331	CcSEcCtD
Clomipramine—Loss of consciousness—Octreotide—thymus cancer	0.0026	0.0033	CcSEcCtD
Clomipramine—Cough—Octreotide—thymus cancer	0.00258	0.00327	CcSEcCtD
Clomipramine—Convulsion—Octreotide—thymus cancer	0.00256	0.00325	CcSEcCtD
Clomipramine—Hypertension—Octreotide—thymus cancer	0.00256	0.00324	CcSEcCtD
Clomipramine—Chest pain—Octreotide—thymus cancer	0.00252	0.00319	CcSEcCtD
Clomipramine—Myalgia—Octreotide—thymus cancer	0.00252	0.00319	CcSEcCtD
Clomipramine—Arthralgia—Octreotide—thymus cancer	0.00252	0.00319	CcSEcCtD
Clomipramine—Anxiety—Octreotide—thymus cancer	0.00251	0.00318	CcSEcCtD
Clomipramine—HTR2A—hematopoietic system—thymus cancer	0.0025	0.0119	CbGeAlD
Clomipramine—Unspecified disorder of skin and subcutaneous tissue—Octreotide—thymus cancer	0.0025	0.00317	CcSEcCtD
Clomipramine—Discomfort—Octreotide—thymus cancer	0.00249	0.00316	CcSEcCtD
Clomipramine—Dry mouth—Octreotide—thymus cancer	0.00246	0.00312	CcSEcCtD
Clomipramine—SLC6A2—lung—thymus cancer	0.00242	0.0115	CbGeAlD
Clomipramine—Anaphylactic shock—Octreotide—thymus cancer	0.00242	0.00306	CcSEcCtD
Clomipramine—Oedema—Octreotide—thymus cancer	0.00242	0.00306	CcSEcCtD
Clomipramine—Shock—Octreotide—thymus cancer	0.00238	0.00301	CcSEcCtD
Clomipramine—Nervous system disorder—Octreotide—thymus cancer	0.00237	0.003	CcSEcCtD
Clomipramine—Thrombocytopenia—Octreotide—thymus cancer	0.00237	0.003	CcSEcCtD
Clomipramine—Tachycardia—Octreotide—thymus cancer	0.00236	0.00299	CcSEcCtD
Clomipramine—Skin disorder—Octreotide—thymus cancer	0.00235	0.00297	CcSEcCtD
Clomipramine—Hyperhidrosis—Octreotide—thymus cancer	0.00234	0.00296	CcSEcCtD
Clomipramine—CYP3A4—hematopoietic system—thymus cancer	0.00232	0.011	CbGeAlD
Clomipramine—Anorexia—Octreotide—thymus cancer	0.0023	0.00292	CcSEcCtD
Clomipramine—HTR2A—epithelium—thymus cancer	0.00229	0.0108	CbGeAlD
Clomipramine—CYP2D6—hematopoietic system—thymus cancer	0.00228	0.0108	CbGeAlD
Clomipramine—GSTP1—lymph node—thymus cancer	0.00226	0.0107	CbGeAlD
Clomipramine—ADRA2A—cardiac atrium—thymus cancer	0.00224	0.0106	CbGeAlD
Clomipramine—Musculoskeletal discomfort—Octreotide—thymus cancer	0.0022	0.00279	CcSEcCtD
Clomipramine—Insomnia—Octreotide—thymus cancer	0.00218	0.00277	CcSEcCtD
Clomipramine—ADRA2A—pituitary gland—thymus cancer	0.00218	0.0104	CbGeAlD
Clomipramine—Paraesthesia—Octreotide—thymus cancer	0.00217	0.00275	CcSEcCtD
Clomipramine—Dyspnoea—Octreotide—thymus cancer	0.00215	0.00273	CcSEcCtD
Clomipramine—Somnolence—Octreotide—thymus cancer	0.00215	0.00272	CcSEcCtD
Clomipramine—Dyspepsia—Octreotide—thymus cancer	0.00213	0.00269	CcSEcCtD
Clomipramine—Decreased appetite—Octreotide—thymus cancer	0.0021	0.00266	CcSEcCtD
Clomipramine—Gastrointestinal disorder—Octreotide—thymus cancer	0.00209	0.00264	CcSEcCtD
Clomipramine—Fatigue—Octreotide—thymus cancer	0.00208	0.00264	CcSEcCtD
Clomipramine—Pain—Octreotide—thymus cancer	0.00207	0.00262	CcSEcCtD
Clomipramine—Constipation—Octreotide—thymus cancer	0.00207	0.00262	CcSEcCtD
Clomipramine—CYP1A2—thyroid gland—thymus cancer	0.00205	0.00971	CbGeAlD
Clomipramine—Feeling abnormal—Octreotide—thymus cancer	0.00199	0.00252	CcSEcCtD
Clomipramine—Gastrointestinal pain—Octreotide—thymus cancer	0.00198	0.0025	CcSEcCtD
Clomipramine—ALB—lymph node—thymus cancer	0.00193	0.00917	CbGeAlD
Clomipramine—Urticaria—Octreotide—thymus cancer	0.00192	0.00243	CcSEcCtD
Clomipramine—Body temperature increased—Octreotide—thymus cancer	0.00191	0.00242	CcSEcCtD
Clomipramine—Abdominal pain—Octreotide—thymus cancer	0.00191	0.00242	CcSEcCtD
Clomipramine—ADRA2A—thyroid gland—thymus cancer	0.00188	0.00892	CbGeAlD
Clomipramine—HTR2B—lymph node—thymus cancer	0.00186	0.00883	CbGeAlD
Clomipramine—CYP1A2—lung—thymus cancer	0.00186	0.00882	CbGeAlD
Clomipramine—HTR2A—pituitary gland—thymus cancer	0.00186	0.0088	CbGeAlD
Clomipramine—Hypersensitivity—Octreotide—thymus cancer	0.00178	0.00226	CcSEcCtD
Clomipramine—Asthenia—Octreotide—thymus cancer	0.00173	0.0022	CcSEcCtD
Clomipramine—ADRA2A—lung—thymus cancer	0.00171	0.00811	CbGeAlD
Clomipramine—Pruritus—Octreotide—thymus cancer	0.00171	0.00217	CcSEcCtD
Clomipramine—SLC6A2—lymph node—thymus cancer	0.00165	0.00784	CbGeAlD
Clomipramine—Diarrhoea—Octreotide—thymus cancer	0.00165	0.00209	CcSEcCtD
Clomipramine—ABCB1—hematopoietic system—thymus cancer	0.00164	0.00778	CbGeAlD
Clomipramine—Dizziness—Octreotide—thymus cancer	0.0016	0.00202	CcSEcCtD
Clomipramine—Vomiting—Octreotide—thymus cancer	0.00154	0.00195	CcSEcCtD
Clomipramine—Rash—Octreotide—thymus cancer	0.00152	0.00193	CcSEcCtD
Clomipramine—Dermatitis—Octreotide—thymus cancer	0.00152	0.00193	CcSEcCtD
Clomipramine—Headache—Octreotide—thymus cancer	0.00151	0.00192	CcSEcCtD
Clomipramine—ABCB1—epithelium—thymus cancer	0.0015	0.00711	CbGeAlD
Clomipramine—HTR2A—lung—thymus cancer	0.00145	0.00689	CbGeAlD
Clomipramine—Nausea—Octreotide—thymus cancer	0.00143	0.00182	CcSEcCtD
Clomipramine—ABCB1—pituitary gland—thymus cancer	0.00122	0.00577	CbGeAlD
Clomipramine—ADRA2A—lymph node—thymus cancer	0.00117	0.00554	CbGeAlD
Clomipramine—ABCB1—lymphoid tissue—thymus cancer	0.00116	0.00548	CbGeAlD
Clomipramine—ABCB1—bone marrow—thymus cancer	0.00105	0.00499	CbGeAlD
Clomipramine—ABCB1—thyroid gland—thymus cancer	0.00105	0.00497	CbGeAlD
Clomipramine—ABCB1—lung—thymus cancer	0.000953	0.00452	CbGeAlD
Clomipramine—ABCB1—lymph node—thymus cancer	0.000652	0.00309	CbGeAlD
